4SC has now received orphan drug status for its cutaneous T-cell lymphoma (CTCL) treatment from the US, EU and Swiss regulatory boards
The healthcare industry is entering a transformative era with the emergence of digital technologies. Innovations such as wearable sensors to monitor vital signs and AI-powered...